← Back to Search

Electrolyte Supplement

Lidocaine-ineffective ADHD: Intervention for Attention Deficit Hyperactivity Disorder (ADHD)

Phase 1 & 2
Waitlist Available
Led By Michael M Segal, MD PhD
Research Sponsored by AlkaliDx, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and ~1 hour after intervention
Awards & highlights

Study Summary

Randomized, controlled, double-blind trial of the effect of a single dose of potassium on ADHD symptoms as measured by changes in measures of symptoms of ADHD correlated with the results of their Lidocaine Effectiveness Test.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and ~1-2 hours later, 1 hour after intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and ~1-2 hours later, 1 hour after intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Prevalence of lidocaine ineffectiveness in those with ADHD
Secondary outcome measures
Change in ADHD-RS questionnaires
Change in Clinical Global Impression Physician Completed Questionnaire
Change in scores using Quotient ADHD System
+2 more

Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: Lidocaine-ineffective ADHD: InterventionActive Control1 Intervention
Single-dose potassium gluconate oral capsule intervention for ADHD subjects for whom lidocaine is ineffective
Group II: Lidocaine-effective ADHD: InterventionActive Control1 Intervention
Single-dose potassium gluconate oral capsule intervention for ADHD subjects for whom lidocaine is effective
Group III: Lidocaine-effective ADHD: PlaceboPlacebo Group1 Intervention
Single-dose placebo oral capsule intervention for ADHD subjects for whom lidocaine is effective
Group IV: Lidocaine-ineffective ADHD: placeboPlacebo Group1 Intervention
Single-dose placebo oral capsule intervention for ADHD subjects for whom lidocaine is ineffective

Find a Location

Who is running the clinical trial?

AlkaliDx, Inc.Lead Sponsor
Michael M Segal, MD PhDPrincipal InvestigatorPhenoSolve, LLC
2 Previous Clinical Trials
45 Total Patients Enrolled
Mark Mintz, MDPrincipal InvestigatorCNNH & CRCNJ

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Single-dose Potassium Supplementation in Patients With ADHD for Whom the Anesthetic Lidocaine is Ineffective
2018. "Single-dose Potassium Supplementation in Patients With ADHD for Whom the Anesthetic Lidocaine is Ineffective". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03563573.
All > Adhd
~15 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top